Clinical Trial Update: Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety study of an adenovirus vector delivering PNP in combination with Fludarabine Phosphate for solid tumors, including head and neck cancer; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Adenovirus/PNP (Adenovirus vector encoding PNP)
• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: PNP Therapeutics, Inc. | Conditions: Head and Neck Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-06-10